“The Triptan's Hangover”: A Multicentric Cross-sectional Observational Study of the Adverse Events of Triptans in Patients With Migraine

The emergence of triptans represented a breakthrough in the treatment of migraine, but in clinical practice, patients describe symptoms that resemble those of a hangover after taking them. We propose the use of the Hangover Symptoms Scale (HSS) to evaluate this syndrome in patients that take triptans, which may help identify patients at higher risk of presenting these adverse effects that may interfere with therapeutic compliance.
Source: Clinical Neuropharmacology - Category: Neurology Tags: Original Articles Source Type: research